Toronto Memory Program is an independent research facility with a large on-site memory clinic as well as a movement disorders and general neurology clinic. We have a dedicated research team experienced in the conduct of clinical trials. Our areas of research interest include: Alzheimer’s disease and related disorders, Parkinson’s disease, and migraine. Our research team consists of: regulatory specialists, qualified investigators, clinical research coordinators, certified psychometric raters, infusionists, pharmacy staff, data entry personnel, laboratory technicians, and recruitment specialists. We have a large and secure facility with assessment and examination rooms, infusion centre, patient procedure room, specimen prep lab, on-site pharmacy, and monitoring rooms. All research equipment is regularly calibrated and investigational product is temperature-monitored to the required specifications.
We have a proven track record in trial acquisition, rapid study start-up, first patient screened and enrolled in Canada, high recruitment and retention metrics, and high quality data. We have had a Health Canada inspection which yielded no observations.
Our site has participated in over 180 clinical trials, and has contributed 1000’s of subjects to phase 1, 2 and 3 clinical trials. We have established strong relationships with a broad range of major pharma and biotech sponsors and CROs. We work with central IRB’s and independent neuro-imaging facilities and have access to 1.5 T and 3 T MRI as well as a variety of ligands for PET imaging. We regularly perform lumbar punctures on-site for CSF analysis.
Our clinical practice provides an ongoing source of study participants. Our Clinical Trial Educators and recruitment team also work in the community to increase awareness of research opportunities. We are located in the heart of the Greater Toronto Area and have access to a large and highly diverse, multicultural patient population in both the urban and surrounding rural areas.
Our Site Principal Investigator, Dr. Sharon Cohen, is a Key Opinion Leader in Alzheimer’s disease and a frequent consultant and advisor to industry and not-for-profit organizations. She is has a longstanding commitment to improving therapeutics for Alzheimer’s disease and other neurodegenerative disorders.
Dr. Sharon Cohen is the Medical Director and site Principal Investigator of Toronto Memory Program. She is a Canadian-trained behavioural neurologist and former Speech Language Pathologist. She is an assistant professor in the University of Toronto, Division of Neurology, as well as the Graduate Department of Speech Language Pathology.
Toronto Memory Program is Canada’s largest and most experienced site for drug treatment trials in Alzheimer’s disease and related conditions. Founded in 1996, Toronto Memory Program has made significant contributions to more than 180 drug treatment studies in Alzheimer’s disease.